Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
Authors:
- Nikolay N. MurashkinNMNikolay N. Murashkin
- Alexander I. MaterikinAMAlexander I. Materikin
- Eduard T. AmbarchianEAEduard T. Ambarchian
- Roman V. EpishevRERoman V. Epishev
- Leonid A. OpryatinLOLeonid A. Opryatin
- Roman A. IvanovRIRoman A. Ivanov
- Daria S. KukolevaDKDaria S. Kukoleva
- Daria G. KuptsovaDKDaria G. Kuptsova
- Marina U. PomazanovaMPMarina U. Pomazanova
Open Access
- 27 December 2020
- journal article
- review article
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 19 (6) , 444-451
Abstract
Psoriasis is chronic inflammatory skin disease that can develop at any age. Approximately 20–30% of all patients report about first rashes before the age of 18. Psoriatic arthritis is one of psoriasis comorbid conditions. Its signs can range from mild to extremely severe destructive forms. Arthralgia, joint stiffness and swelling are the most common symptoms. Early psoriatic arthritis treatment onset allows to control joint damage which usually occurs during the first 2 years of the disease. The moderate and severe course of psoriasis and psoriatic arthritis may require systemic therapy, however, there is not much data on the efficacy and toxicity of systemic agents in the pediatric practice. This article provides the review of studies on etanercept efficacy and safety in children with psoriatic arthritis.Keywords
This publication has 44 references indexed in Scilit:
- Ultrasonographic Assessment of Nail in Psoriatic Disease Shows a Link between Onychopathy and Distal Interphalangeal Joint Extensor Tendon EnthesopathyDermatology, 2012
- Enthesitis in Psoriatic DiseaseDermatology, 2012
- Psoriatic Arthritis and Onycholysis — Results from the Cross-sectional Reykjavik Psoriatic Arthritis StudyThe Journal of Rheumatology, 2012
- Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trialJournal of the American Academy of Dermatology, 2011
- Intermittent etanercept therapy in pediatric patients with psoriasisJournal of the American Academy of Dermatology, 2010
- Safety and efficacy of etanercept treatment in children and adolescents with plaque psoriasis: 96-week results of open-label extension studyJournal of the American Academy of Dermatology, 2010
- Epidemiology and comorbidity of psoriasis in childrenBritish Journal of Dermatology, 2009
- Juvenile Psoriatic Arthritis: Bathwater or Baby?The Journal of Rheumatology, 2009
- The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological studyRheumatology, 2006
- Etanercept: An overviewJournal of the American Academy of Dermatology, 2003